These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6950354)

  • 1. [Proceedings of the 5th National Conference on Medical Cytogenetics. Ancona, 11-12 April 1980. Abstracts].
    Pathologica; 1981; 73(1024):291-404. PubMed ID: 6950354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myelogenous leukemia. Correlation between clinical, laboratory and cytogenetic data (author's transl)].
    Lisker R; Pérez-Chávez F; Casas L; Córdova MS; Mutchinick O
    Rev Invest Clin; 1980; 32(2):187-92. PubMed ID: 6932688
    [No Abstract]   [Full Text] [Related]  

  • 3. 13th International Chromosome Conference. September 8-12. Ancona, Italy. Abstracts.
    Cytogenet Cell Genet; 1998; 81(2):95-168. PubMed ID: 9745620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytogenetics of preleukemic states].
    Benítez Ortiz J
    Rev Esp Oncol; 1982; 29(3):445-56. PubMed ID: 6965032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetics of recurrent acute leukemia].
    Charrin C; Mugneret F
    Rev Prat; 1996 Jan; 46(1):37-41. PubMed ID: 8596889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of occupational genotoxicants. Proceedings of a satellite symposium to the Fourth International Conference on Environmental Mutagens. Helsinki, Finland, June 30-July 2, 1985.
    Prog Clin Biol Res; 1986; 207():1-250. PubMed ID: 3960867
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of human cytogenetics for research on human evolution].
    Bullerdiek J; Bartnitzke S
    Anthropol Anz; 1982 Jun; 40(2):81-9. PubMed ID: 7114824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining prognosis of acute myeloid leukemia patients.
    Haematologica; 2000 Mar; 85(3):226. PubMed ID: 10702807
    [No Abstract]   [Full Text] [Related]  

  • 10. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
    Caligiuri MA; Strout MP; Lawrence D; Arthur DC; Baer MR; Yu F; Knuutila S; Mrózek K; Oberkircher AR; Marcucci G; de la Chapelle A; Elonen E; Block AW; Rao PN; Herzig GP; Powell BL; Ruutu T; Schiffer CA; Bloomfield CD
    Cancer Res; 1998 Jan; 58(1):55-9. PubMed ID: 9426057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
    Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of cytogenetics in acute myeloid leukaemia.
    Mrózek K; Heinonen K; Bloomfield CD
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
    Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
    Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and molecular cytogenetics and gene mapping: principles and techniques.
    Francke U
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():34-43. PubMed ID: 8629138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myeloid disorders: background.
    Swansbury J
    Methods Mol Biol; 2003; 220():23-42. PubMed ID: 12744204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
    Sandberg AA; Chen Z
    In Vivo; 1994; 8(5):807-18. PubMed ID: 7727729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.